Free Webcast: An Update on Biosimilars and Their Impact on Innovation

Jan. 25, 2010 - PRLog -- Follow-on biologics, or biosimilars, will soon become reality in the U.S. Given their inherent complexity and the current state of analytics, how will their safety and quality be ensured? Will they boost or diminish competition and innovation in biotech? Most importantly, how have recent shifts in the health care reform debate changed the outlook of biosimilars legislation, and how could legislation stifle the innovation inherent in the biotech industry?

Join PharmaManufacturing.com for a thought-provoking presentation and panel discussion of these issues on January 28, 2009, at 11 AM E.T. (8 AM P.T.) in the U.S.

Speakers include:

Matthew Hudes, U.S. Managing Principal for Biotechnology, Deloitte Consulting

Jim Hollingshead, Principal for Strategy and Operations, Deloitte Consulting

James Blackwell, Senior Consultant, BioProcess Technology Consultants, Inc.

The program is sponsored by Kronos, Ahura Scientific, and DSM. To register, please visit: http://www.visualwebcaster.com/event.asp?id=64758